Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2023-04-04 00:00:00 ET · period of report 2023-02-28 · accession 0001104659-23-041742 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-04-04 | 2023-02-28 | ANIP | Lalwani Nikhil | Pres, CEO, Dir | A - Grant | $0.00 | +159.2K | 346.4K | +85% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-28 | A | A | 63,686 | $0.00 | 410,056 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-28 | A | A | 95,530 | $0.00 | 346,370 | D | — | — |